Skip to main content

ArriVent BioPharma, Inc.

For the period ended Mar 17, 2026. Filed Mar 17, 2026.

View on SEC.gov

About this filing

A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.

Mar 17, 2026 · Filed Mar 17, 2026

AVBP$14.16+3.8%Stored close · as of Nov 9, 2026
Opening this filing…